Nanofibers media is now possible using Hills Inc's special meltblowing die and Celanex Next Generation JKX-1158 polymer. Celanex JKX-1158 provided the high strength and low fly necessary to achieve 300-400nm fibers.
Specialty chemicals group LANXESS has developed a new high-performance rubber additive - Nanoprene. This material additive for the rubber mixture of the tire tread significantly cuts wear in automobile tires.
The 7th Annual Nano Applications & Advanced Materials Forum on February 5-6, 2008 in Palm Springs, CA will bring together the leaders who are building, leveraging, and financing the global economy’s nanotechnology-enabled applications and advanced materials.
International advanced composites group Quickstep Holdings Limited has hit the ground running in 2008, today announcing the commencement of aircraft parts manufacturing at its Australian headquarters located in Fremantle, Western Australia - marking the first stage in establishing the site as a fully equipped, world-class aerospace manufacturing facility.
Professor Joseph DeSimone, Liquidia Technologies founder and Distinguished Professor of Chemistry at the University of North Carolina at Chapel Hill and Chemical Engineering at North Carolina State University, has been named a Triangle Impact Entrepreneur for his contributions to innovative nanoparticle therapeutics and a targeted drug delivery platform at Liquidia Technologies.
SUSS MicroTec, a leading supplier of precision manufacturing and test equipment for the semiconductor and emerging markets, announced today it has shipped and successfully installed several microelectromechanical systems production tools at Freescale Semiconductor.
SUSS MicroTec Lithography GmbH, a leading manufacturer and supplier of production and process lithography systems now holds the globally recognized ISO 9001 certification for having established a high level process- and system-oriented quality management (QM) based on ISO9001 quality standards.
Carigent Therapeutics, Inc., announced today that the National Cancer Institute of the National Institutes of Health has awarded Carigent a one-year, $153,000 Phase I Small Business Innovation Research grant to advance preclinical development of an innovative, long-circulating nanoparticle therapeutic that targets the specific molecular lesions in non-Hodgkin's lymphoma patients.
Advantages allow solar manufacturers to cut selected manufacturing costs by 50%, while increasing relative device quantum efficiencies by as much as 5%. Materials deliver more light to the active region of the solar cell; Turnkey process allows elimination of CVD tools.
Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, will host the upcoming 'Investment In Innovation (In3) Europe' conference April 29-30, 2008 at The Hilton Paris Hotel in Paris, France.
GE Global Research, the centralized research organization of the General Electric Company, announced that scientists on their Nano Photovoltaics team have demonstrated a scalable silicon nanowire-based solar cell, which has the potential to achieve up to 18% efficiency and be produced at a dramatically lower cost than conventional solar cells.
Making solar energy cheaper and more efficient is the aim of a new licensing deal between the University of California, Davis, and Q1 NanoSystems. The university and the company, based in West Sacramento, Calif., have agreed on terms for exclusive licensing of a package of jointly-owned intellectual property stemming from inventions both on and off campus.
JumpStart Inc., Northeast Ohio's venture development organization, has made an investment commitment of $350,000 in Advanced Materials Technology International LLC (AMTI). The Cleveland-based company is developing and commercializing a line of high-tech, energy-curable, nanoparticle materials for ink and coatings applications.
Nanobac Pharmaceuticals Inc. announces that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles in surgically resected gallbladders with cholelithiasis (Gall Stones). This potentially represents a previously unrecognized factor in the development of cholecystitis and cholelithiasis disease.